SeaStar Medical Holding Corp
ICU
Company Profile
Business description
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Contact
3513 Brighton Boulevard
Suite 410
DenverCO80216
USAT: +1 844 427-8100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
12
Stocks News & Analysis
stocks
Vote in favour of merger for undervalued ASX share
We recommend shareholders vote in favor of its proposed merger.
stocks
Are investors missing the boat on this future ASX leader?
The market is underestimating the clear path to profitability.
stocks
ASX shares plunge but remain undervalued
Shares drop 17% after guidance is revised but we still see value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,569.10 | 112.30 | 1.33% |
| CAC 40 | 7,634.74 | 160.15 | 2.14% |
| DAX 40 | 20,655.39 | 80.71 | 0.39% |
| Dow JONES (US) | 43,241.03 | 19.48 | 0.05% |
| FTSE 100 | 8,391.90 | 90.77 | 1.09% |
| HKSE | 19,522.89 | 236.82 | 1.23% |
| NASDAQ | 19,450.63 | 60.60 | -0.31% |
| Nikkei 225 | 38,572.60 | 128.02 | 0.33% |
| NZX 50 Index | 13,000.67 | 57.10 | 0.44% |
| S&P 500 | 5,952.97 | 3.06 | 0.05% |
| S&P/ASX 200 | 8,327.00 | 113.70 | 1.38% |
| SSE Composite Index | 3,236.03 | 8.92 | 0.28% |